Risk factors for developing pneumonia in patients with diabetes mellitus following acute ischaemic stroke

Journal of International Medical Research

Volumn 40, Issue 5, 2012, Pages 1860-1865

  Zhang, Xudong ^a   Wang, F ^a   Zhang, Y ^b   Ge, Z ^b  

^a GANSU PROVINCIAL HOSPITAL   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

Acute ischaemic stroke; C reactive protein; Diabetes mellitus; Interleukin 6; Pneumonia

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ADVERSE OUTCOME; AGE; AGED; ARTICLE; BODY TEMPERATURE; BRAIN ISCHEMIA; DIABETES MELLITUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DYSPHAGIA; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PNEUMONIA; PREDICTIVE VALUE; PREVALENCE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANKIN SCALE; RISK ASSESSMENT; BLOOD; CEREBROVASCULAR ACCIDENT; METABOLISM; PATHOLOGY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DEGLUTITION DISORDERS; DIABETES COMPLICATIONS; HUMANS; INTERLEUKIN-6; PNEUMONIA; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 84880634946     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006051204000524     Document Type: Article

References (33)

1. Hong KS, Kang DW, Koo JS, et al: Impact of neurological and medical complications on 3- month outcomes in acute ischaemic stroke. Eur J Neurol 2008; 15: 1324-1331.
2. Katzan IL, Cebul RD, Husak SH, et al: The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 2003; 60: 620-625.
3. Langhorne P, Stott DJ, Robertson L, et al: Medical complications after stroke: a multicenter study. Stroke 2000; 31: 1223-1229.
4. Ovbiagele B, Hills NK, Saver JL, et al: Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. J Stroke Cerebrovasc Dis 2006; 15: 209-213.
5. Sellars C, Bowie L, Bagg J, et al: Risk factors for chest infection in acute stroke: a prospective cohort study. Stroke 2007; 38: 2284-2291.
6. Dirnagl U, Klehmet J, Braun JS, et al: Strokeinduced immunodepression: experimental evidence and clinical relevance. Stroke 2007; 38: 770-773.
7. Chamorro A, Urra X, Planas AM: Infection after acute ischemic stroke: a manifestation of braininduced immunodepression. Stroke 2007; 38: 1097-1103.
8. Puavilai G, Chanprasertyotin S, Sriphrapradaeng A: Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Res Clin Pract 1999; 44: 21-26.
9. Mann G, Hankey GJ, Cameron D: Swallowing function after stroke: prognosis and prognostic factors at 6 months. Stroke 1999; 30: 744-748.
10. Alberti KG, Zimmet P, Shaw J: Metabolic syndrome-a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
11. Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
12. Libby P, Bonow RO, Mann D, et al (eds): Braunwald’s Heart Disease: a Textbook of Cardiovascular Medicine, 8th edn, Part VIII: Atherosclerosis cardiovascular disease. Philadelphia: Elsevier Saunders, 2008.
13. The National Institutes of Health (NIH): The NIH Stroke Scale (NIHSS), International Electronic Education Network™. Cedar Park, TX: TrainingCampus.com® 1999-2012 (available at: http://www.nihstrokescale.org/).
14. Cincura C, Pontes-Neto OM, Neville IS, et al: Validation of the National Institutes of Health Stroke Scale, modified Rankin Scale and Barthel Index in Brazil: the role of cultural adaptation and structured interviewing. Cerebrovascular Dis 2009; 27: 119-122.
15. Vermeij FH, Scholte op Reimer WJ, de Man P, et al: Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc Dis 2009; 27: 465-471.
16. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, et al: Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med 2004; 164: 1761-1768.
17. Hilker R, Poetter C, Findeisen N, et al: Nosocomial pneumonia after acute stroke: implications for neurological intensive care medicine. Stroke 2003; 34: 975-981.
18. Walter U, Knoblich R, Steinhagen V, et al: Predictors of pneumonia in acute stroke patients admitted to a neurological intensive care unit. J Neurol 2007; 254: 1323-1329.
19. Larkin JG, Frier BM: Diabetes mellitus and infection. Postgrad Med J 1985; 61: 233-237.
20. Kammersgaard LP, Jørgensen HS, Reith J, et al: Early infection and prognosis after acute stroke: the Copenhagen Stroke Study. J Stroke Cerebrovasc Dis 2001; 10: 217-221.
21. Hamidon BB, Raymond AA, Norlinah MI, et al: The predictors of early infection after an acute ischaemic stroke. Singapore Med J 2003; 44: 344-346.
22. Pittock SJ, Meldrum D, Hardiman O, et al: The Oxfordshire Community Stroke Project classification: correlation with imaging, associated complications, and prediction of outcome in acute ischemic stroke. J Stroke Cerebrovasc Dis 2003; 12: 1-7.
23. Kwan J, Hand P: Infection after acute stroke is associated with poor short-term outcome. Acta Neurol Scand 2007; 115: 331-338.
24. Vargas M, Horcajada JP, Obach V, et al: Clinical consequences of infection in patients with acute stroke: is it prime time for further antibiotic trials? Stroke 2006; 37: 461-465.
25. Emsley HC, Hopkins SJ: Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008; 7: 341-353.
26. Chamorro A, Amaro S, Vargas M, et al: Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J Neurol Neurosurg Psychiatry 2006; 77: 1279-1281.
27. Hug A, Dalpke A, Wieczorek N, et al: Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke 2009; 40: 3226-3232.
28. Liesz A, Hagmann S, Zschoche C, et al: The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 2009; 40: 2849-2858.
29. Chamorro A, Amaro S, Vargas M, et al: Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci 2007; 252: 29-35.
30. Schwarz S, Al-Shajlawi F, Sick C, et al: Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim Infection in Stroke Study (MISS). Stroke 2008; 39: 1220-1227.
31. Harms H, Prass K, Meisel C, et al: Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial. PLoS One 2008; 3: e2158.
32. Chamorro A, Horcajada JP, Obach V, et al: The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke 2005; 36: 1495-1500.
33. Lampl Y, Boaz M, Gilad R, et al: Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 2007; 69: 1404-1410.